The Glucosamine market research report analyzes the market by Type and Application at global level and for each of the geographic regions - North America, Europe, China, Asia-Pacific, Latin America and Rest of World. The Glucosamine market is segmented by Type into D-Glucosamine and N-Acetyl-Glucosamine; and by Application into Nutraceutical/Pharmaceutical, Feed Additives, and Nutraceuticals/Pharmaceutical. Business profiles of 60 major companies are discussed in the report. The research report serves as a guide to Glucosamine industry covering 239 companies that are engaged in Glucosamine R&D, processing, production, and distribution. The research report also covers companies engaged in glucosamine based products. Information related to recent product releases, product developments, partnerships, collaborations, mergers and acquisitions, ethical issues, regulatory affairs, and other areas of concern is also covered in the report. Projections and estimates are graphically illustrated by geographic region with exclusive graphical representations provided for 285 exhibits.

Free Sample Research Report

Download Table of contents

Global Glucosamine market is projected to grow at more than 13% compounded annually from 2000 through 2013. China, the leading market (45% of global market share in 2006) for Glucosamine presently is projected to retain the leading position during the analysis period with its share dropping to 36% by 2013. North America is the fastest growing (17.8% during 2000-2013) market for Glucosamine, (33% market share by 2013) almost at par with China by the end of the analysis period. North America is followed by Europe in terms of growth rate with a CAGR of 16.1%.

Glucosamine is the most sought after product in terms of joint health. It may not be a complete cure for Osteoarthritis, but with mounting scientific proof and some of the world's leading manufacturers behind it, there could be a good profit in the glucosamine functional food market. The application of Glucosamine in other fields such as body building, wound healing, inflammatory bowel disorders etc. has considerably increased the need and production of Glucosamine.

Cargill is the major supplier of US-produced glucosamine. Its brand, Regenasure, made from a non-shellfish source, is now also cleared for sale in Japan and the UK. Other suppliers such as Ethical Naturals etc are now producing vegetarian glucosamine.

Countries Covered:
North America
United States
Canada
Europe
United Kingdom
Germany
Spain
Czech Republic
Rest of Europe
China
Asia-Pacific
Japan
Australia
India
Rest of Asia-Pacific
Rest of world

A & Z Food Additives Co., Ltd. (China)
Auromed Ltd. (UK)
Bayir Chemicals (India)
Bio-Alternatives (USA)
Bioiberica (Spain)
Bioprex Labs (India)
Biosourcing.com (P) Ltd. (India)
Cargill, Inc. (USA)
Coastal Laboratories (India)
Dongying Development Zone Marine Organism Chemical Co., Ltd. (China)
Exotic Naturals (India)
Fraken Biochem Co., Ltd. (China)
HangZhou Peak Chemicals Company Ltd. (PeakChem) (China)
Hebei Sanxin Industry Group Co., Ltd. (China)
Hygieia Health Products (Hong Kong)
JFC Technologies (USA)
Kraeber GmbH & Co. (Germany)
Lytone Enterprise, Inc. (Taiwan)
Norbrook Laboratories Ltd. (UK)
Norwegian Chitosan Ltd. (Norway)
Pacific Rainbow International, Inc. (USA)
Pharmed Medicare (India)
Pharmline Inc. (USA)
Sai Gluco Pharma (India)
Sai Sukush, Inc. (India)
SEPAC Co., Ltd. (China)
Shandong Rongcheng Luyang Chemical Co., Ltd. (China)
Shandong Yibao Biologics Co., Ltd. (China)
Shine Star (Hubei) Biological Engineering Co., Ltd. (China)
Shreeji Pharma International (India)
Shubhmets (India)
Sinochem Qingdao Co., Ltd. (China)
Sinoway International (Jiangsu) Co., Ltd. (China)
Taizhou Candorly Sea Biochemical & Health Products Co., Ltd. (China)
Triarco Industries, Inc. (USA)
TSI Health Sciences (USA)
Wanbury Ltd. (India)
Wellable Group Marine Biological & Chemical Co., Ltd. (China)
Yaizu Suisankagaku Industry Co., Ltd. (Japan)
Zhejiang Aoxing Biotechnology Co., Ltd. (China)
Zhejiang Medicines & Health Products I/E Co., Ltd. (ZMC) (China)
Zhejiang Shinfuda Pharmaceutical Co., Ltd. (China)

GLUCOSAMINE PRODUCTS
Aim Companies (The) (USA)
AniMed (USA)
Astamed Healthcare (I) Pvt. Ltd. (India)
Cyanotech Corporation (USA)
DTC Health, Inc. (USA)
Navamedic ASA (Norway)
NUPRO (USA)
Perrigo Company (USA)
PrimePharm Health Co., Ltd. (China)
Rottapharm SpA (Italy)
SCOLR Pharma, Inc. (USA)
Seven Seas Ltd. (UK)
Stina Resources Ltd. (Canada)
Synflex America Inc. (USA)
Unipharm, Inc. (USA)
William Ransom & Son PLC. (UK)
Zylera Pharmaceuticals (USA)

For those who are intrested to buy the report by chapter:

CHAPTER	TITLE	SHORT DESCRIPTION	PRICE (US$)
I	Scope and Methodology	This chapter provides information regarding the research methodology, limitations of the study, market measuring units and exchange rates used. * Will be delivered free with purchase of any of the other chapters mentioned below.	FREE*
II	Report Synopsis	Synopsis of the report summarizes the global market, by Glucosamine Type and Application. Global market is also analyzed by geographic regions including North America, Europe, China, Asia-Pacific, Latin America and Rest of World. The chapter provides market values in US$ from 2000 through 2013 for each geographic region including the US, Canada, UK, Germany, Spain, Czech Republic, China, Japan, India, and Australia.	$1250
III	Product / Technology Research	This chapter gives an insight into Glucosamine market including definitions, segmentation and applications. The chapter also includes product trends and potential opportunities. Information regarding Glucosamine based drugs is also provided.	$800
IV	Market Dynamics	Market Dynamics chapter provides information on global markets for Glucosamine. The chapter includes global market analysis (in US$) by geographic region; analysis of each region by both Type and Application; brief business profiles of major global Glucosamine producers and Glucosamine product manufacturers; and a report of corporate activities such as mergers and acquisitions, partnerships, new product developments/launches, etc. The section includes key market trends and an industry outlook.	$1600
V	Corporate Directory	This chapter provides a global region-wise list of more than 230 companies, CROs and academic institutions that offer Glucosamine as raw material and products and/or services.	$300